Chronic Gout Management
12 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the aim of chronic gout management?

  • To promote joint damage
  • To accelerate acute flares
  • To maintain the 'intercritical' phase (correct)
  • To increase tophi formation
  • How is joint damage primarily caused in chronic gout?

  • By excessive synovial fluid production
  • By immune system malfunction
  • Due to bacteria invasion
  • Through granuloma formation or crystalline deposition (correct)
  • What role does urate-lowering therapy (ULT) play in treating gout?

  • It increases uric acid levels in the body
  • It reduces the body's uric acid levels (correct)
  • It induces tophi formation
  • It promotes acute flares
  • Which medication is recommended for severe chronic gout that does not respond to other therapies?

    <p>Pegloticase</p> Signup and view all the answers

    What process does pegloticase perform in the body?

    <p>Breaks down uric acid to allantoin</p> Signup and view all the answers

    Why might it be debated whether 'intercritical' gout should be treated more aggressively?

    <p>'Intercritical' gout can still cause joint destruction without attacks</p> Signup and view all the answers

    What is the primary excretion route of Febuxostat?

    <p>Urine</p> Signup and view all the answers

    Which drug is rapidly metabolized to oxipurinol, its active form?

    <p>Allopurinol</p> Signup and view all the answers

    What do Xanthine Oxidase Inhibitors (XOIs) primarily target in gout treatment?

    <p>Xanthine oxidase activity</p> Signup and view all the answers

    Which condition is a contraindication for Uricosuric Agents?

    <p>Conditions increasing uric acid production or decreasing kidney function</p> Signup and view all the answers

    What is the unique feature of Pegloticase among ULT agents?

    <p>Intravenous administration and recombinant polyethylene glycolated Uch-A specific enzyme conjugate</p> Signup and view all the answers

    Why has the clinical use of uricosuric agents diminished over time?

    <p>'s potential risks and limitations have become more evident</p> Signup and view all the answers

    More Like This

    CMS150 week 4 - joint pain
    38 questions

    CMS150 week 4 - joint pain

    UserReplaceableQuail avatar
    UserReplaceableQuail
    Gout: Pathophysiology and Management Quiz
    18 questions
    Pharmacology Chapter on Gout Treatment
    5 questions
    Use Quizgecko on...
    Browser
    Browser